Surrey Heartlands

Joint Formulary & PAD

Terbutaline (nebules / injection) - Asthma

You are here : Home > Formulary Search > Terbutaline (nebules / injection) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Nebules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important

Specialist recommendation following patient initiation and education on nebuliser therapy

 

Status 2

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important
Severe acute asthma

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Terbutaline (nebules / injection)
Indication :
Asthma
Group Name :
SABA
Keywords :
Severe acute asthma, severe respiratory disease, nebuliser therapy
Brand Names Include :
Bricanyl Respules, Bricanyl injection
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Asthma
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Terbutaline (nebules / injection) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Terbutaline nebules:

The Respiratory Care Team will ensure that the patient has undergone a suitable trial and training re use of equipment, response and safety.  After this trial GPs may prescribe following a request from the respiratory care team. The advice will include frequency and duration of treatment, and whether additional support is required for the patients, e.g. wrap around frequent or long-term steroids.